CB2 Insights Adds Former Johnson & Johnson Executive as Director

NEXT STORY
Forty Seven Inc. to Present at Canaccord Genuity 39th Annual Growth Conference
PREV STORY
Clearside Biomedical Announces Multiple Oral Presentations Delivered at the American Society of Retinal Specialists (ASRS) Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TG Therapeutics Announces Preclinical and Clinical Data Evaluating TG-1701 at the 16th International Congress on Malignant Lymphoma

author_avatar
NASDAQ Market News

Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation

author_avatar
NASDAQ Market News

Immunocore Announces Pricing of Upsized Initial Public Offering

author_avatar
NASDAQ Market News